Would you like to join a company bringing innovative brain-wave monitoring products to the market?
Do you want to develop software for UNEEG medical’s products; products that can help improve the quality of life for people suffering from diabetes or epilepsy?
And do you want to influence the development of our software?
A Cloud/PC Software architect, a Cloud/PC software developer; an App developer and a software tester.
At UNEEG medical we combine the newest knowledge with a natural curiosity when we develop products for brain wave monitoring. We have recently released the “UNEEG 24/7” – the only device in the world for ultra-long-term brain wave monitoring and we are right now facing an international market launch.
You will be part of a smaller software team, that is responsible for all software applications such as PC software, Cloud software, App software and embedded software. We have recently released our first concept and are now expanding with Apps and Cloud based systems and we also integrate our software solutions to existing software systems via cooperation with the manufacturers of these systems.
We expect that you (depending on the position):
Please submit your application and CV (in English or Danish) no later than September 6th 2019. We will screen and invite candidates for interviews from September on an ongoing basis.
Please mark your application with the relevant position “Cloud/PC Architect”, “Cloud/PC Developer”; “App Developer” or “Software tester”.
If you have any questions regarding the position or company, you are welcome to contact Head of Software John Colberg, by email firstname.lastname@example.org who will be available from August 27th 2019 due to summer holidays.
The company was founded in 2005 and is owned by T&W Medical A/S. UNEEG medical A/S is a sister company to WS Audiology A/S – a merger between former Danish Widex A/S and Sivantos Pte. Ltd.. UNEEG medical is an entrepreneurial and ambitious company, pioneering cognitive technologies that collect, monitor and measure brain activity (EEG). The devices can be used for medical and diagnostic purposes within epilepsy and detect and alert diabetics of severe hypoglycaemia, hence aiming at improving patients’ quality of life. UNEEG medical employs approximately 60 people, has just gained CE marking for the first products and is facing an international market launch. This requires several new functions and competencies. The office is located in Lynge in innovative and energy-optimised buildings powered by wind energy. Read more at www.uneeg.com.